Derek Lowe submits: You may or may not have noticed, but slowly and quietly, Merck (MRK) has been getting many of the large Vioxx judgments against it overturned on appeal . These cases made huge headlines when they were first tried, but the articles that tell the end of the story have not, for the most part, made the front page. This is one reason that the company was finally able to settle a huge number of pending lawsuits for much less than many people thought likely. Merck seemed to like its chances, considering the cases they’d won and the way things looked in the appeals courts, and the amount of money they were able to settle for finally became a better deal for them than the alternative of fighting out every case. Of course, now people are starting to wonder if the company settled too soon - opinions differ . Complete Story » ...